Dr. Reddy's Laboratories (RDY) return on equity (ROE)

Return on equity · fiscal 2026
11.4%

Dr. Reddy's Laboratories (RDY) earned a return on equity of 11.4% in fiscal 2026 (the year ended March 31, 2026). That is 5.6 percentage points lower than the 17.0% of fiscal 2025. Figures as of 18 Nov 2026, 02:51 UTC, from Yahoo Finance.

Key facts

Return on equity, fiscal 2026
11.4%
Change on fiscal 2025
−5.6 pts
Highest on record
19.8%fiscal 2024
Lowest on record
11.4%fiscal 2026
Fiscal years on record
42023–2026

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Dr. Reddy's Laboratories return on equity (ROE), in more detail

Across the 4 fiscal years on record (2023–2026), the highest was 19.8% in fiscal 2024 and the lowest 11.4% in fiscal 2026. The fiscal 2026 figure is no higher than in any of the 3 earlier fiscal years on record, whose median is 19.5%.

History · 4 fiscal years

Return on equity by fiscal year

Dr. Reddy's Laboratories return on equity (ROE), year by year

Dr. Reddy's Laboratories (RDY) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202611.4% 5.6 pts down
202517.0% 2.9 pts down
202419.8% 0.3 pts up
202319.5%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Dr. Reddy's Laboratories and comparable companies
CompanyReturn on equityFiscal year
Smith & Nephew SNN11.8%2025
Penumbra PEN12.4%2025
Dr. Reddy's Laboratories RDY11.4%2026
Align Technology ALGN10.1%2025
Cooper Companies COO4.6%2025
Fresenius Medical Care FMS7.4%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RDY

Dr. Reddy's Laboratories, figure by figure

Dr. Reddy's Laboratories (RDY) overview: price, valuation and scorecardAll health care companies by market value

Dr. Reddy's Laboratories return on equity (ROE): questions and answers

What is Dr. Reddy's Laboratories's return on equity?

Dr. Reddy's Laboratories (RDY) earned a return on equity of 11.4% in fiscal 2026 (the year ended March 31, 2026). That is 5.6 percentage points lower than the 17.0% of fiscal 2025.

Is Dr. Reddy's Laboratories's return on equity high or low compared with its own history?

The fiscal 2026 figure is no higher than in any of the 3 earlier fiscal years on record, whose median is 19.5%.

What are the highest and lowest return on equity figures on record for Dr. Reddy's Laboratories?

Across the 4 fiscal years on record (2023–2026), the highest was 19.8% in fiscal 2024 and the lowest 11.4% in fiscal 2026.

How is Dr. Reddy's Laboratories's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Dr. Reddy's Laboratories (RDY) return on equity (ROE)”, data as of 18 November 2026. https://funkfolio.com/stock/RDY/roe

Underlying data: Yahoo Finance.